This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

Chemistry, Manufacturing, and Control Strategies for Peptides and Oligonucleotides

Share this article

This fall TIDES USA returned to Boston for a live, in-person event, aimed to bring attendees strategies to accelerate their therapeutics from laboratory to market. TIDES Europe was live in Brussels, Belgium in November 2021. The presentations shared leading strategies for expediting research and development and improving chemistry, manufacturing, and control (CMC) efficiencies.

In this ebook, we look at not only how to improve process efficiencies and overcome challenges in process development and scale-up, CMC and manufacturing, but also take a look at regulatory expectations, new technologies and alternative approaches for emerging complex molecules. This includes a look at mRNA therapeutics and vaccines from industry-leading companies.

Includes presentation overviews from the recent TIDES events, with insights from Asahi Kasei Bioprocess, BfArM (The Federal Institute for Drugs and Medical Devices, Germany), GSK, Editas Medicine, BioNTech and more.

Share this article

Upcoming event

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum

07 - 09 Mar 2023, Kyoto, Japan
Industry leaders and service providers share cutting-edge content and company expertise across the Oligonucleotide, Peptide, mRNA and Drug Delivery spectrum
Go to site